FDx Advisors’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,206
Closed -$141K 707
2023
Q3
$141K Buy
+10,206
New +$149K 0.01% 610
2019
Q3
Sell
-28,193
Closed -$325K 755
2019
Q2
$325K Buy
28,193
+1,477
+6% +$19K 0.01% 609
2019
Q1
$375K Buy
26,716
+13,380
+100% +$175K 0.02% 536
2018
Q4
$138K Buy
+13,336
New +$197K 0.01% 535
2014
Q4
Sell
-9,913
Closed -$322K 940
2014
Q3
$322K Sell
9,913
-2,045
-17% -$69.5K 0.02% 756
2014
Q2
$418K Buy
11,958
+2,479
+26% +$81.4K 0.03% 648
2014
Q1
$300K Sell
9,479
-932
-9% -$25.9K 0.03% 613
2013
Q4
$264K Buy
+10,411
New +$249K 0.03% 568

Other funds holding PTEN

FDx Advisors's PTEN Position: Q4 2023 in Review

FDx Advisors sold out of Patterson-UTI (PTEN) in Q4 2023, closing a stake of 10,206 shares — an estimated $141K sold.

FDx Advisors first reported a position in PTEN in Q4 2013 and held it in 8 quarters. The position peaked at $418K in Q2 2014. 359 funds tracked by Wall St. Rank hold PTEN as of Q4 2023.

  • FDx Advisors reported no remaining Patterson-UTI position as of Q4 2023 after selling out during the quarter.
  • FDx Advisors sold 10,206 Patterson-UTI shares in Q4 2023, an estimated $141K.
  • FDx Advisors first reported a position in Patterson-UTI in Q4 2013 and held it in 8 quarters.
  • FDx Advisors's Patterson-UTI position peaked at $418K in Q2 2014.
  • 359 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2023.

Based on FDx Advisors's 13F filing for Q4 2023, filed 13 Feb 2024.